A study out of Brazil suggests that a simple, low-cost supplement could meaningfully improve how well chemotherapy works against breast cancer. Researchers at the Botucatu School of Medicine at São Paulo State University (FMB-UNESP) found that women who took daily vitamin D alongside chemotherapy were 79% more likely to achieve complete tumor disappearance than women who took a placebo.
At a glance
- Vitamin D supplementation: Women took 2,000 IU of vitamin D daily during chemotherapy — a modest, cost-effective dose rather than a high corrective one.
- Complete response rate: 43% of women in the vitamin D group saw their cancer fully disappear, compared to 24% in the placebo group.
- Study population: 80 women aged 45 and older, all receiving chemotherapy before surgery to shrink their tumors, most of whom were vitamin D-deficient at the start.
Why this finding matters
Breast cancer is the most commonly diagnosed cancer in women worldwide. Chemotherapy before surgery — called neoadjuvant chemotherapy — is a standard approach for many patients, and how completely the tumor responds to that treatment is a strong predictor of long-term outcomes.
A therapy that costs a few dollars a month and could raise the complete response rate by that margin is worth taking seriously. The researchers note that vitamin D is widely available, easy to take, and carries a well-established safety profile at this dose.
Most women in the study were deficient in vitamin D before treatment began — a common finding in cancer patients and in the general population. Correcting that deficiency during chemotherapy may have given the immune system more to work with.
How vitamin D may support cancer treatment
Vitamin D is best known for its role in bone health, but its influence on the immune system runs deeper. It helps regulate immune cell activity and has been shown in lab studies to affect how cancer cells grow and die. The UNESP researchers believe restoring adequate vitamin D levels may help the body respond more aggressively to the cancer during treatment.
What makes the UNESP approach notable is the dose. Rather than using the high supplementation levels sometimes used to rapidly correct deficiency, the team used 2,000 IU daily — a level considered safe for long-term use and practical for integration into a standard treatment plan.
Limitations and next steps
The researchers are careful not to overstate the results. The trial included only 80 participants, and the findings have not yet been replicated at scale. Larger, randomized clinical trials are needed before vitamin D can be formally recommended as a routine add-on for breast cancer chemotherapy.
Still, the direction of the finding is clear and the cost of further investigation is low. The research was published in a peer-reviewed oncology context and adds to a growing body of evidence linking nutritional status and cancer treatment outcomes.
Vitamin D deficiency is also not evenly distributed. Populations with darker skin tones, limited sun exposure, and lower incomes face higher deficiency rates — meaning an affordable supplement-based intervention could matter most for communities that already face worse cancer outcomes. That equity angle is one more reason researchers say follow-up work is urgent.
For now, the UNESP team recommends that oncologists consider testing patients’ vitamin D levels at the start of treatment. Supplementation at a modest dose carries little risk and, if this study holds up, may meaningfully shift the odds in a patient’s favor.
Read more
For more on this story, see: OnlyMyHealth
For more from Good News for Humankind, see:
- U.K. cancer death rates fall to their lowest level on record
- Alzheimer’s risk cut in half by drug in landmark prevention trial
- The Good News for Humankind archive on global health
About this article
- 🤖 This article is AI-generated, based on a framework created by Peter Schulte.
- 🌍 It aims to be inspirational but clear-eyed, accurate, and evidence-based, and grounded in care for the Earth, peace and belonging for all, and human evolution.
- 💬 Leave your notes and suggestions in the comments below — I will do my best to review and implement where appropriate.
- ✉️ One verified piece of good news, one insight from Antihero Project, every weekday morning. Subscribe free.
More Good News
-
Germany finishes 60-year project turning coal mines into a 23-lake district
Germany’s Lusatian Lakeland is now complete — a chain of 23 human-made lakes covering 14,000 hectares where open-cast coal mines once scarred the land between Berlin and Dresden. The final piece, Lake Sedlitz, opened to swimmers and boaters this April, and in June, five of the lakes will be linked by navigable canals into a continuous 5,000-hectare waterway. Engineers spent decades channeling river water into the old craters, securing embankments, and flushing out acid — work that would have taken nature a century. The region now welcomes around 800,000 overnight stays a year, with former miners finding work in hospitality…
-
Brazilian researchers find vitamin D boosts breast cancer chemo by 79%
Vitamin D may give breast cancer chemotherapy a meaningful boost, according to a new Brazilian trial in which 43% of women taking a daily supplement saw their tumors disappear completely, compared to 24% on a placebo. Researchers at São Paulo State University gave 80 patients a modest 2,000 IU dose alongside their standard pre-surgery chemo — a level safe enough for everyday use and cheap enough for almost anyone. Most women in the study were vitamin D-deficient to begin with, a pattern common in cancer patients worldwide. If larger trials confirm the finding, it points to something rare and hopeful…
-
Chinese solar exports double in last month to hit record high
China’s solar exports hit a record 68.03 gigawatts in March 2026, nearly doubling February’s volume as countries raced to replace disrupted Middle Eastern oil and gas. Fifty nations logged all-time-high imports of Chinese solar equipment that month, with African countries jumping 176% from February alone. Behind those numbers are governments that had been moving cautiously on renewables and suddenly found solar to be the fastest, cheapest answer on the table. Battery and electric vehicle shipments climbed alongside the panels, hinting at a clean-energy package moving together. The takeaway is hopeful even amid hard circumstances: when fossil fuels falter, the world…
